FEATURED CONTRIBUTED CONTENT

Social Media in Life Sciences: Adoption and Trends Benchmarking Report


Social Media in Life Sciences: Adoption and Trends Benchmarking Report

Findings reveal that based on the industry’s current level of participation in social media, utilization of technology, and effectiveness of social programs, the pharma industry is in the early stages of social media maturity. In fact, only 13% of those that participated in the study indicated that they find their current social media programs as very […]

August 29, 2016 More Clinical »
Clinical Trial Knowledge Platform: The Road To Compliance


Clinical Trial Knowledge Platform: The Road To Compliance

Regulatory scrutiny in clinical research has intensified in recent years, and there are no signs that the intensity of the regulatory environment is abating. In the context of increased outsourcing of clinical study activity to CROs, inspectors are showing an increased interest in evidence of the sponsor fulfilling their remaining oversight obligations. One step to improving the […]

August 30, 2016 More Clinical »
Tim Davis is Changing the Clinical Trials Landscape


Tim Davis is Changing the Clinical Trials Landscape

Tim Davis, Founder and CEO of Exco InTouch, is a pioneer in the clinical trials technology space. One of the 2016 PharmaVOICE 100, Davis has been busy since founding Exco InTouch in 2004. Here are just a few of the company’s accomplishments under Tim’s leadership: • First to use mobile phones for patient engagement in […]

August 24, 2016 More Clinical »
The Election’s Impact on Pharma: Preparing for Potential Scenarios


The Election’s Impact on Pharma: Preparing for Potential Scenarios

The 2016 election will have a major impact on both federal and state healthcare policy. To be sure your organization is prepared for all the possibilities, it’s critical to understand the political dynamics that will be at play under each potential scenario—and what they will mean for the life sciences industry. In a new podcast, […]

September 13, 2016 More Clinical »
Rare Disease: Taking a Different Approach


Rare Disease: Taking a Different Approach

An estimated 400 million people worldwide are currently living with rare diseases. There are approximately 7,000 different types of rare diseases and disorders, with more being discovered every day. At best, the knowledge base about any individual rare disease is small, fragmented, and often the preserve of a relatively few thought leaders and experts in the field. Moreover, […]

August 15, 2016 More Clinical »
Best Practices for your Next Tracking Study


Best Practices for your Next Tracking Study

The tracking study is a cornerstone of good market research. But what happens when you are faced with budget cuts, unforeseen market changes, or urgent data needs? Powerful, real-time tracking technologies can help fill these gaps and complement your traditional ATU when you need answers quickly. In this webinar, you will learn how this new […]

October 19, 2016 More Clinical »
Piloting the Queen Mary: The Unique Challenges of Cardiovascular Outcome Studies


Piloting the Queen Mary: The Unique Challenges of Cardiovascular Outcome Studies

Cardiovascular outcome studies can be a bit like piloting the Queen Mary – multiple compartments, complex interrelated activities, difficult to launch and bring into port. To commemorate World Heart Day on September 29th, Worldwide Clinical Trial experts will highlight common challenges and key success factors, as well as design and operational conventions in cardiovascular outcome […]

September 29, 2016 More Clinical »
The ACA’s Section 1332 Waivers: Will We See More State Innovation in Health Care Reform?


The ACA’s Section 1332 Waivers: Will We See More State Innovation in Health Care Reform?

While the Affordable Care Act continues to be politically polarizing, stakeholders from across the health reform landscape are focused on effectively implementing the law and on making incremental – not radical – changes to it. The question is how such change might happen given the deep national divisions about what corrections are needed. One answer […]

September 13, 2016 More Clinical »
FEEDBACK